A Prospective Randomized Non-inferiority Trial to Compare Operative Versus Non-operative Treatment for ER-stress Positive Weber-B Unimalleolar Fractures
A Prospective Randomized Non-inferiority Trial to Compare Operative Versus Non-operative Treatment for ER-stress Positive Weber-B Unimalleolar Fractures
Current gold standard treatment for unstable (those found unstable in external rotation (ER) stress testing Weber B-type, Lauge-Hansen supination-external rotation type IV) ankle fractures is open reduction and internal fixation (ORIF) with semitubular plates and screws. However, there is some preliminary evidence to suggest that these type of fibula fractures can be managed non-operatively with comparable functional outcome. The aim of this randomized, non-inferiority trial is to assess whether non-operative treatment (cast immobilisation) yields a non-inferior functional outcome compared to surgery with no excess harms (primarily, fracture and wound healing problems and infection).
Seventy per cent of ankle fractures are unimalleolar injuries, the Weber B -type of fibula fracture being by far the most common type. The ankle mortise can either be stable or unstable in this type of fracture depending on the accompanying soft tissue injury. The stability of the ankle mortise has fundamental clinical relevance, as it dictates the subsequent treatment strategy. If left untreated, an unstable ankle mortise may lead to fracture healing complications and increased risk of post-traumatic osteoarthritis and subsequently poor functional outcome. Therefore, current clinical practice guidelines recommend surgical treatment for these injuries. The gold standard surgical treatment for unstable ankle fractures is open reduction and internal fixation (ORIF) using 1/3 semi-tubular plates and screws.
The most common complication following operative treatment of ankle fracture is wound infection, the incidence ranging from 6.1 to10% in unselected patient materials.
To date, there is only one published randomized trial comparing operative and non-operative treatment in patients with an unstable unimalleolar fibula fracture. In this 1-year follow-up, the authors concluded that patients managed nonoperatively had equivalent functional outcomes compared with operative treatment; however, the risk of fracture displacement and problems with union was substantially higher in patients managed nonoperatively. In turn, 10/41 (24%) patients treated operatively were re-operated; five patients had a post-operative infection and five patients required hardware removal.
This prospective randomized non-inferiority trial is designed to compare surgical and non-operative treatment of ER-stress positive unimalleolar ankle fractures. The primary, non-inferiority, intention-to-treat outcome is the Olerud-Molander Ankle Score at 104 weeks or 24 months (OMAS; range, 0-100; higher scores indicating better outcome and fewer symptoms). The predefined non-inferiority margin for the primary outcome at the primary assessment time point is 8 points. Secondary outcomes are ankle function, pain, quality of life, ankle range of motion, and radiographic outcome. Follow-up assessments are performed at 2, 6, 12, and 104 weeks (primary time point). Treatment related complications and harms; symptomatic non-unions, loss of congruity of the ankle joint, and wound infections are also recorded.
The ER-stress test is performed by a consultant trauma orthopedic surgeon or a trauma resident who has completed trauma rotation. Medial clear space opening of 5 mm or more will be considered a positive ER stress test. Patients are randomized to non-operative or surgical treatment using a sealed envelope method. Surgical treatment is carried out using a standard open reduction and internal fixation with 1/3 semitubular plate and screws. Post-operatively, surgically treated ankles are placed in a below-the-knee cast for six weeks. They are advised to carry out partial weight-bearing (15 to 20 kilograms) for the first four weeks and then weight-bear as tolerated for the remaining two weeks. The non-operative treatment protocol is similar to that of the surgically treated patients: six-week below-the-knee cast with partial weight-bearing for the first four weeks and then weight-bearing as tolerated for the remaining two weeks.
Inclusion Criteria:
Exclusion Criteria: